Norwood Immunology is a Company focused upon therapies based upon the use of Stem Cells in Regenerative Medicine, Rejuvenation of the Immune System and Cell Transfection.  In addition, it is a party to agreements  related to technology associated with the use of Virosomes as the basis for the Delivery of Vaccines.

NIM is associated with four core platform technologies:-

• The use of ‘adult’ stem cells in the treatment of both injuries and degenerative conditions in both humans and animals
  
  
• Rejuvenation of the Thymus and the Adult Immune System with a resulting enhancement of T Cell proliferation and immune system responsiveness.
  
  
• The use of Virosomes in Cell Transfection
  
  
• The use of Virosomes to enhance the delivery and efficacy of Vaccines